EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Development of Novel Radiopharmaceuticals for SPECT and PET

Bianca Gutfilen iD

Pharmaceuticals · 28.05.2026 · 19 (6) · 841

DOI: 10.3390/ph19060841 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 28.05.2026. Verfasst von Bianca Gutfilen. Beteiligte Einrichtung: Department of Radiology, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear Medicine has experienced remarkable advances over the past few decades, driven primarily by the development of new radiopharmaceuticals for both conventional applications and positron emission tomography (PET) [...]

Autor:innen und Institutionen

  • Department of Radiology, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil.

ORCID-Profile: Bianca Gutfilen

Zitieren

APA

Gutfilen, B. (2026). Development of Novel Radiopharmaceuticals for SPECT and PET. Pharmaceuticals, 19(6), 841. https://doi.org/10.3390/ph19060841

Vancouver

Gutfilen B. Development of Novel Radiopharmaceuticals for SPECT and PET. Pharmaceuticals. 2026;19(6):841. doi:10.3390/ph19060841

BibTeX
@article{Gutfilen2026,
  author = {Gutfilen, Bianca},
  title = {Development of Novel Radiopharmaceuticals for SPECT and PET},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {841},
  doi = {10.3390/ph19060841}
}
Kostenlos starten →